Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • 2019
  • Article
  • Journal of Behavioral Economics for Policy

Pay-for-Monopoly?: An Assessment of Reverse Payment Deals by Pharmaceutical Companies

By: Sana Rafiq and Max Bazerman
  • Format:Electronic
  • | Pages:7
ShareBar

Abstract

Abstract Over the past eighteen years, pharmaceutical firms have developed a blueprint to impede competition in order to maintain their monopoly profits. This scheme, termed pay-for-delay, involves direct or indirect payment of money from a branded-drug manufacturer to a generic-drug producer to stay out of market. In most cases, the payment is shrouded as a side deal, where the generic-drug entrant agrees to stay out of the market in return for overpayment on some unrelated agreement from the branded drug company. These agreements are signed at the same time, or even within the same legal agreement. While the Federal Trade Commission has often asserted that these agreements restrict trade by keeping the generic off the market at the expense of consumers, traditional expert economists have developed a number of defenses for such practices. Drawing on insights from behavioral economics, we argue that these agreements are very unlikely to be pro-competitive. We suggest solutions, both judicial and legislative, that would lead generic drugs to the market faster, providing more medicine to those that need it at a more affordable price.

Keywords

Monopoly; Policy; Competition; Agreements and Arrangements; Pharmaceutical Industry

Citation

Rafiq, Sana, and Max Bazerman. "Pay-for-Monopoly? An Assessment of Reverse Payment Deals by Pharmaceutical Companies." Journal of Behavioral Economics for Policy 3, no. 1 (2019): 37–43.
  • Read Now

About The Author

Max H. Bazerman

Negotiation, Organizations & Markets
→More Publications

More from the Authors

    • Spring 2025
    • Journal of Law, Medicine & Ethics

    An Insider’s Perspective on How to Reduce Fraud in the Social Sciences

    By: Max Bazerman
    • February 2025
    • Faculty Research

    Slice Labs: Creating a Fraud-Free Online Insurance Platform

    By: Amit Goldenberg, Max Bazerman and Ruth Page
    • February 2025
    • Faculty Research

    Slice Labs: Creating a Fraud-Free Online Insurance Platform (B)

    By: Amit Goldenberg, Max Bazerman and Ruth Page
More from the Authors
  • An Insider’s Perspective on How to Reduce Fraud in the Social Sciences By: Max Bazerman
  • Slice Labs: Creating a Fraud-Free Online Insurance Platform By: Amit Goldenberg, Max Bazerman and Ruth Page
  • Slice Labs: Creating a Fraud-Free Online Insurance Platform (B) By: Amit Goldenberg, Max Bazerman and Ruth Page
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.